Related Experiment Video

Updated: Aug 21, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate

Shahram Misaghi1, Paul J Galardy, Wim J N Meester

  • 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.

The Journal of Biological Chemistry
|November 9, 2004
PubMed

Insights

Ubiquitin C-terminal hydrolases (UCHs) are proteases with unknown functions. This study reveals human UCH-L3 can hydrolyze larger ubiquitin conjugates, suggesting a broader role for UCH enzymes in cellular processes.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Enzymology

Background:

  • Ubiquitin C-terminal hydrolases (UCHs) are a family of proteases with largely unknown cellular functions.
  • Tissue-specific expression and disease associations suggest critical roles for UCHs, particularly UCH-L1.
  • Previous structural data indicated potential substrate size limitations for UCH enzymes.

Purpose of the Study:

  • To determine the structure of human UCH-L3 in complex with an inhibitor.
  • To compare the structure of UCH-L3 in free and ligand-bound states.
  • To investigate the substrate specificity and catalytic cycle of UCH family members.

Main Methods:

  • X-ray crystallography of human UCH-L3 with ubiquitin vinylmethylester at 1.45 A resolution.
  • Biochemical assays to assess the hydrolysis of ubiquitin-conjugated peptides by UCH-L3.

Main Results:

  • The crystal structure of human UCH-L3-inhibitor complex was determined, confirming inhibitor binding mechanism.
  • Direct comparison of free and ligand-bound UCH-L3 structures was enabled.
  • Human UCH-L3 efficiently hydrolyzed a 13-residue peptide linked to ubiquitin, indicating flexibility in substrate size.

Conclusions:

  • Human UCH-L3 exhibits flexibility in handling larger ubiquitin conjugates than previously predicted.
  • The findings support a model for the catalytic cycle of UCH enzymes that accommodates larger substrates.
  • This research provides insights into the functional mechanisms of ubiquitin-specific proteases.

More Related Videos

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

Related Concept Videos

The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...